Guinea-Bissau vs Niger: Share of children with symptoms of a respiratory infection who received antibiotics
Guinea-Bissau
23.7%
in 2018
Niger
29.4%
in 2018
Guinea-Bissau rank
131st
Niger rank
129th
Share of children with symptoms of a respiratory infection who received antibiotics over time
- Guinea-Bissau
- Niger
How they compare
Niger currently reports 29.4% against 23.7% in Guinea-Bissau, a difference of 5.7%.
That makes Niger's figure about 1.2 times Guinea-Bissau's.
The two have swapped places 5 times across 19 shared years of data; in 2000 it was Guinea-Bissau ahead.
Guinea-Bissau ranks 131st and Niger ranks 129th of 132 countries.
Guinea-Bissau has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Guinea-Bissau | Niger | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 32.3% | 31.7% | 0.6% | Guinea-Bissau |
| 2010s | 34.5% | 33.5% | 1.1% | Guinea-Bissau |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of children with symptoms of a respiratory infection who received antibiotics, Guinea-Bissau or Niger?
- Niger, at 29.4% against 23.7% in Guinea-Bissau as of 2018.
- What is the difference in share of children with symptoms of a respiratory infection who received antibiotics between Guinea-Bissau and Niger?
- 5.7%, with Niger ahead.
- How many years of comparable data are there for Guinea-Bissau and Niger?
- 19 years are reported by both, from 2000 to 2018.
- How do Guinea-Bissau and Niger rank globally for share of children with symptoms of a respiratory infection who received antibiotics?
- Guinea-Bissau ranks 131st and Niger ranks 129th of 132 countries.
- Where does this data come from?
- Browne AJ et al. (2021) – processed by Our World in Data, published as Share of children with symptoms of a respiratory infection who received antibiotics. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Caregiver reported share of children under five years old, with symptoms of lower respiratory tract infection, who received antibiotics for this illness.